What risk of cardiovascular birth defects has been reported with fluoxetine use during the first trimester?

Some epidemiological studies suggest that first-trimester fluoxetine exposure increases the risk of cardiovascular birth defects to approximately 2 in 100 infants, compared with approximately 1 in 100 in the general population; the mechanism is unknown.